MedPath

KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER

🇸🇦Saudi Arabia
Ownership
-
Employees
-
Market Cap
-
Website
http://kaimrc.med.sa/

Clinical Trials

47

Active:0
Completed:24

Trial Phases

5 Phases

Phase 1:1
Phase 2:6
Phase 3:3
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (42 trials with phase data)• Click on a phase to view related trials

Not Applicable
29 (69.0%)
Phase 2
6 (14.3%)
Phase 3
3 (7.1%)
Phase 4
3 (7.1%)
Phase 1
1 (2.4%)

Wireless Monitoring for Clinical Deterioration

Not Applicable
Not yet recruiting
Conditions
Inpatient Facililty Diagnoses
First Posted Date
2024-10-16
Last Posted Date
2024-10-16
Lead Sponsor
King Abdullah International Medical Research Center
Target Recruit Count
13160
Registration Number
NCT06644599

Viral Etiology of Severe Acute Respiratory InFection in CriticallY Ill Patients Registry

Terminated
Conditions
Severe Acute Respiratory Infection
First Posted Date
2024-10-04
Last Posted Date
2024-10-04
Lead Sponsor
King Abdullah International Medical Research Center
Target Recruit Count
13
Registration Number
NCT06627166
Locations
🇸🇦

Intensive Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia

The Effect of Whey Protein Consumption on Hypoglycemia in Adults with Type 1 Diabetes During Fasting Ramadan.

Not Applicable
Completed
Conditions
Type1 Diabetes
Fasting
Nutrition, Healthy
First Posted Date
2024-09-13
Last Posted Date
2024-09-13
Lead Sponsor
King Abdullah International Medical Research Center
Target Recruit Count
44
Registration Number
NCT06595550
Locations
🇸🇦

King Abdullah International Research Centre, Jeddah, Saudi Arabia

Smart-phone Application Versus Conventional Paper for the Documentation of Voiding Dysfunction in Children

Not Applicable
Not yet recruiting
Conditions
Voiding Dysfunction
Children
First Posted Date
2024-05-08
Last Posted Date
2024-05-22
Lead Sponsor
King Abdullah International Medical Research Center
Target Recruit Count
100
Registration Number
NCT06404996

Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs.

Phase 3
Recruiting
Conditions
Dexmedetomidine
Midazolam
Withdrawal Symptoms
Failure of Extubation
Interventions
First Posted Date
2022-08-03
Last Posted Date
2023-04-27
Lead Sponsor
King Abdullah International Medical Research Center
Target Recruit Count
430
Registration Number
NCT05485519
Locations
🇸🇦

King Abdullah Specialist Children Hospital (KASCH), Riyadh, Saudi Arabia

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.